ARSENIC ALTERS CYTOSINE METHYLATION PATTERNS OF THE PROMOTER OF THE TUMOR-SUPPRESSOR GENE P53 IN HUMAN LUNG-CELLS - A MODEL FOR A MECHANISMOF CARCINOGENESIS
Mj. Mass et Lj. Wang, ARSENIC ALTERS CYTOSINE METHYLATION PATTERNS OF THE PROMOTER OF THE TUMOR-SUPPRESSOR GENE P53 IN HUMAN LUNG-CELLS - A MODEL FOR A MECHANISMOF CARCINOGENESIS, Mutation research-reviews in mutation research, 386(3), 1997, pp. 263-277
Arsenic is a potent human carcinogen to which there is significant wor
ldwide exposure through natural contamination of food and drinking wat
er sources. Because arsenic is detoxified via methylation using a meth
yltransferase (MTase) and S-adenosylmethionine (SAM) as the methyl don
or, we hypothesized that a mechanism of carcinogenesis of arsenic coul
d involve alterations of MTase/SAM-dependent DNA methylation of a tumo
r suppressor gene. We found that exposure of human lung adenocarcinoma
A549 cells to sodium arsenite (0.08-2 mu M) or sodium arsenate (30-30
0 mu M), but not dimethylarsenic acid (2-2000 mu M), produced signific
ant dose-responsive hypermethylation within a 341-base pair fragment o
f the promoter of p53. This was determined by quantitative PCR/HpaII r
estriction site analysis to analyze methylation status of two CCGG sit
es, In experiments with arsenite, DNA sequencing using bisulfite to vi
sualize 5-methylcytosine (5-MeC) over the entire promoter region confi
rmed data obtained by restriction analysis. Limited data using SssI me
thylase also suggested that over-methylation of CpG sequences may exis
t over the entire genome in response to arsenite exposure. We propose
that alteration of DNA methylation by arsenic offers a plausible, unif
ied hypothesis for the carcinogenic mechanism of action of arsenic, an
d we present a model for arsenic carcinogenesis that utilizes perturba
tions of DNA methylation as the basis for the carcinogenic effects of
arsenic.